Kyntra Bio, Inc. (KYNB)
7.78
-0.24
(-2.99%)
USD |
NASDAQ |
Aug 31, 16:00
7.65
-0.13
(-1.67%)
After-Hours: 20:00
Kyntra Bio Cash and Short Term Investments (Quarterly) : 91.32M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.32M |
| March 31, 2026 | 87.24M |
| December 31, 2025 | 88.98M |
| September 30, 2025 | 117.98M |
| June 30, 2025 | 23.37M |
| March 31, 2025 | 33.61M |
| December 31, 2024 | 50.48M |
| September 30, 2024 | 131.00M |
| June 30, 2024 | 140.71M |
| March 31, 2024 | 177.60M |
| December 31, 2023 | 203.45M |
| September 30, 2023 | 251.34M |
| June 30, 2023 | 335.72M |
| March 31, 2023 | 355.95M |
| December 31, 2022 | 422.01M |
| September 30, 2022 | 408.52M |
| June 30, 2022 | 438.13M |
| March 31, 2022 | 428.08M |
| December 31, 2021 | 405.19M |
| September 30, 2021 | 486.40M |
| June 30, 2021 | 507.21M |
| March 31, 2021 | 544.23M |
| December 31, 2020 | 686.54M |
| September 30, 2020 | 687.87M |
| June 30, 2020 | 685.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 535.43M |
| December 31, 2019 | 533.76M |
| September 30, 2019 | 628.63M |
| June 30, 2019 | 660.76M |
| March 31, 2019 | 565.40M |
| December 31, 2018 | 621.40M |
| September 30, 2018 | 652.73M |
| June 30, 2018 | 671.90M |
| March 31, 2018 | 703.77M |
| December 31, 2017 | 735.72M |
| September 30, 2017 | 729.97M |
| June 30, 2017 | 359.40M |
| March 31, 2017 | 243.42M |
| December 31, 2016 | 253.18M |
| September 30, 2016 | 241.80M |
| June 30, 2016 | 230.52M |
| March 31, 2016 | 173.41M |
| December 31, 2015 | 181.17M |
| September 30, 2015 | 221.52M |
| June 30, 2015 | 248.66M |
| March 31, 2015 | 142.69M |
| December 31, 2014 | 179.82M |
| September 30, 2014 | 175.50M |
| June 30, 2014 | 202.09M |
| March 31, 2014 | 109.59M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vericel Corp. | 162.46M |
| Capricor Therapeutics, Inc. | 237.93M |
| ARS Pharmaceuticals, Inc. | 143.84M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |